Formulation and evaluation of ondansetron nasal delivery systems

International Journal of Pharmaceutics

Volumn 349, Issue 1-2, 2008, Pages 101-107

  Cho, Eunsook ^a   Gwak, Hyesun ^b   Chun, Inkoo ^a  

^a Dongduk Women's University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Lag time; Ondansetron hydrochloride; Permeation rate; Pharmacokinetic parameters; Vehicles

Indexed keywords

BENZALKONIUM CHLORIDE; CHITOSAN; CYCLODEXTRIN DERIVATIVE; DIMETHYL BETA CYCLODEXTRIN; MACROGOL 300; MACROGOL DERIVATIVE; NICOTINAMIDE; ONDANSETRON; SODIUM DERIVATIVE; SULFOBUTYL ETHER BETA CYCLODEXTRIN SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUTION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REFRIGERATOR;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIEMETICS; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HALF-LIFE; INJECTIONS, INTRAVENOUS; NASAL MUCOSA; ONDANSETRON; PERMEABILITY; RABBITS; RATS; SOLUBILITY; VEHICLES;

EID: 37349035788     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.07.028     Document Type: Article

References (26)

1. Asai K., Morishita M., Katsuta H., Hosoda S., Shinomiya K., Noro M., Nagai T., and Takayama K. The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa. Int. J. Pharm. 246 (2002) 25-35
2. Behl C.R., Pimplaskar H.K., Sileno A.P., deMeireles J., and Romeo V.D. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv. Drug Del. Rev. 29 (1998) 89-116
3. Blackwell C.P., and Harding S.M. The clinical pharmacology of ondansetron. Eur. J. Cancer Clin. Oncol. 25 (1989) S21-S24
4. Butcher M.E. Global experience with ondansetron and future potential. Oncology 50 (1993) 191-197
5. Chien Y.W., Su K.S.E., and Chang S.F. Nasal Systemic Drug Delivery (1989), Marcel Dekker, New York
6. Choi H.J., and Chun I.K. Complexation of progesterone with cyclodextrins and design of aqueous parenteral formulations. J. Korean Pharm. Sci. 31 (2001) 151-160
7. Figg W.D., Dukes G.E., Pritchard J.F., Hermann D.J., Lesesne H.R., Carson S.W., Songer S.S., Powell J.R., and Hak L.J. Pharmacokinetics of ondansetron in patients with hepatic insufficiency. J. Clin. Pharmacol. 36 (1996) 206-215
8. Gwak H.S., Oh I.S., and Chun I.K. In vitro percutaneous absorption of ondansetron hydrochloride from pressure-sensitive adhesive matrices through hairless mouse skin. Arch. Pharm. Res. 26 (2003) 644-648
9. Gwak H.S., Oh I.S., and Chun I.K. Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers. Drug Dev. Ind. Pharm. 30 (2004) 187-194
10. Hirai S., Yashiki T., Matsuzawa T., and Mima H. Absorption of drugs from the nasal mucosa of rat. Int. J. Pharm. 7 (1981) 317-325
11. Harris A.S., Ohlin M., Svensson E., Lethagen S., and Nilsson I.M. Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin. J. Pharm. Sci. 78 (1989) 470-471
12. Hermens W.A., Belder C.W., Merkus J.M., Hooymans P.M., Verhoef J., and Merkus F.W. Intranasal estradiol administration to oophorectomized women. Eur. J. Obstet. Gynecol. Reprod. Biol. 40 (1991) 35-41
13. Hesketh P.J., and Gandara D.R. Serotonin antagonists: a new class of antiemetic agents. J. Natl. Cancer Inst. 83 (1991) 613-620
14. Loftsson T., and Duchêne D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329 (2007) 1-11
15. Marttin E., Verhoef J.C., Spies F., van der Meulen J., Nagelkerke J.F., Koerten H.K., and Merkus F.W.H.M. The effect of methylated β-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: electron microscopic and confocal laser scanning microscopic visualization studies. J. Contr. Rel. 57 (1999) 205-213
16. Matsubara K., Abe K., Irie T., and Uekama K. Improvement of nasal bioavailability of leuteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats. J. Pharm. Sci. 84 (1995) 1295-1300
17. McKenzie R., Kovac A., O'Connor T., Duncalf D., Angel J., Gratz I., Tolpin E., McLeskey C., and Joslyn A. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 78 (1993) 21-28
18. McMartin C., Hutchinson L.E.F., Hyde R., and Peters G.E. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J. Pharm. Sci. 76 (1987) 535-540
19. Merkus F.W.H.M., Verhoef J.C., Martin E., Romejin S.G., and Schipper N.G.M. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats. Pharm. Res. 8 (1991) 588-592
20. Merkus F.W.H.M., Verhoef J.C., Martin E., Romejin S.G., van der Kuy P.H.M., Hermens W.A.J.J., and Schipper N.G.M. Cyclodextrins in nasal drug delivery. Adv. Drug Del. Rev. 36 (1999) 41-57
21. Quraishi M.S., Jones N.S., and Mason J.D. The nasal delivery of drugs. Clin. Otolaryngol. 22 (1997) 289-301
22. Rolia F., and Del Favero A. Ondansetron clinical pharmacokinetics. Clin. Pharmacokinet. 29 (1995) 95-109
23. Sanghvi R., Evans D., and Yalkowsky S.H. Stacking complexation by nicotinamide: a useful way of enhancing drug solubility. Int. J. Pharm. 336 (2007) 35-41
24. Schipper N.G., Verhoef J.C., Romeijn S.G., and Merkus F.W. Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin. Calcif. Tissue Int. 56 (1995) 280-282
25. Scuderi P., Wetchler B., Sung Y.F., Mingus M., DuPen S., Claybon L., Leslie J., Talke P., Apfelbaum J., and Sharifi-Azad S. Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology 78 (1993) 15-20
26. Turker S., Onur E., and Ozer Y. Nasal route and drug delivery systems. Pharm. World Sci. 26 (2004) 137-142